{"id":121489,"date":"2024-10-15T07:00:07","date_gmt":"2024-10-15T11:00:07","guid":{"rendered":"https:\/\/www.send2press.com\/wire\/?p=121489"},"modified":"2024-10-14T20:28:09","modified_gmt":"2024-10-15T00:28:09","slug":"promising-neurotechnology-startups-to-present-at-the-24th-neurotech-leaders-forum","status":"publish","type":"post","link":"https:\/\/www.send2press.com\/wire\/promising-neurotechnology-startups-to-present-at-the-24th-neurotech-leaders-forum\/","title":{"rendered":"Promising Neurotechnology Startups to Present at the 24th Neurotech Leaders Forum"},"content":{"rendered":"

SAN FRANCISCO, Calif., Oct. 15, 2024 (SEND2PRESS NEWSWIRE) — Neurotech Reports<\/a> announced that executives from several emerging neurotechnology startups will present for the first time at the 2024 Neurotech Leaders Forum<\/a>\u00a0in San Francisco, November 6-7. Among the new presenters are Paxos Medical, a firm that has developed a novel neuromodulation therapy for non-obstructive urinary retention.<\/p>\n

\"Axonics
Image caption: Axonics CEO Ray Cohen will keynote the 24th Annual Neurotech Leaders Forum.<\/em><\/p>\n

Also presenting for the first time will be Katya Sverdlov, CEO and co-founder of JelikaLite<\/a>, a clinical stage medtech company focused on the treatment of autism. Another new presenter is Emile Radyte, CEO of Samphire Neuroscience<\/a> in the U.K., which has developed a wearable neuromodulation device for treatment of PMS and menstrual pain.<\/p>\n

Other entrepreneur presenters at this year\u2019s conference include Emily Mirro, President of SynchNeuro Inc<\/a>., Andy Gotshalk, CEO, Neurologic Solutions<\/a>, Luca Ravagnan, CEO of Italian firm WISE srl<\/a>, Kial Gramley of BackStop Neural<\/a>, and Imanuel Lerman, CEO, InflammaSense, Inc<\/a>.<\/p>\n

Raymond Cohen, CEO of Axonics Inc<\/a>., will keynote the 24th annual event\u2014the most established in the industry. Mr. Cohen has served as CEO and member of the board of directors of Axonics since co-founding the company in October 2013. Axonics recently announced it would be acquired by Boston Scientific<\/a> in a $3.7 billion deal.<\/p>\n

Neurotech Reports senior contributing editor JoJo Platt will moderate a panel titled “BCI Frenzy: Separating the Facts from the Hype in the Brain Implant Market,” which will feature executives from several BCI firms. Neurotech Reports senior consulting editor Jeremy Koff will moderate a session titled “Market Share Battles: Neuromodulation\u2019s Competitive Outlook.” Neurotech Reports editor James Cavuoto will moderate a session titled “Looking for the Exit: Investors Exploit Renewed Interest in Neurotech,\u201d which will feature a discussion with key VC professionals. And Neurotech Reports contributing editor Victor Pikov will moderate a session titled “Biomarking Your Territory: Neurosensing Technologies Enhance Closed-Loop Neuromodulation.”<\/p>\n

Platinum Sponsor at this year\u2019s event is Cirtec Medical<\/a>. MST<\/a> is Gold Sponsor. Valtronic<\/a>, Velentium<\/a>, and Neo-Bionica<\/a> are Silver Sponsors, while TTP<\/a>, Osypka<\/a>, Corundum Neuroscience<\/a>, Focus<\/a>, and CorTec<\/a> are Bronze Sponsors.<\/p>\n

For more information, contact Neurotech Reports at 415 546 1259 or visit: http:\/\/neurotechreports.com\/pages\/leadersforum.html<\/a>.<\/p>\n

MULTIMEDIA:<\/strong><\/p>\n

Photo link for media: https:\/\/www.Send2Press.com\/300dpi\/24-1015-s2p-ray-cohen-300dpi.jpg<\/a><\/p>\n

Caption: Axonics CEO Ray Cohen will keynote the 24th Annual Neurotech Leaders Forum in San Francisco, November 6-7, 2024.<\/p>\n","protected":false},"excerpt":{"rendered":"

SAN FRANCISCO, Calif., Oct. 15, 2024 (SEND2PRESS NEWSWIRE) — Neurotech Reports announced that executives from several emerging neurotechnology startups will present for the first time at the 2024 Neurotech Leaders Forum in San Francisco, November 6-7. Among the new presenters are Paxos Medical, a firm that has developed a novel neuromodulation therapy for non-obstructive urinary retention.<\/p>\n","protected":false},"author":3345,"featured_media":121483,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[603,12804,1,10,61,197,103],"tags":[869],"class_list":["post-121489","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-neurotech-news","category-ap","category-business-news","category-california-news","category-health-medical-news","category-event-news","category-san-francisco-news","tag-neurotech-leaders-forum","has-post-title","has-post-date","no-post-category","no-post-tag","no-post-comment","has-post-author"],"acf":[],"views":2641,"_links":{"self":[{"href":"https:\/\/www.send2press.com\/wire\/wp-json\/wp\/v2\/posts\/121489","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.send2press.com\/wire\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.send2press.com\/wire\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.send2press.com\/wire\/wp-json\/wp\/v2\/users\/3345"}],"replies":[{"embeddable":true,"href":"https:\/\/www.send2press.com\/wire\/wp-json\/wp\/v2\/comments?post=121489"}],"version-history":[{"count":0,"href":"https:\/\/www.send2press.com\/wire\/wp-json\/wp\/v2\/posts\/121489\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.send2press.com\/wire\/wp-json\/wp\/v2\/media\/121483"}],"wp:attachment":[{"href":"https:\/\/www.send2press.com\/wire\/wp-json\/wp\/v2\/media?parent=121489"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.send2press.com\/wire\/wp-json\/wp\/v2\/categories?post=121489"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.send2press.com\/wire\/wp-json\/wp\/v2\/tags?post=121489"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}